By Sneha S K and Bageshri Banerjee (Reuters) -The U.S. Food and Drug Administration on Thursday approved Ionis ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

MDMA (Molly, ecstasy) is an empathogen widely used as a club drug that may become a future treatment for PTSD. Many respond ...

The drug known as 7-OH has been on the market for two years, and officials warn of its potential for addiction.

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic ...

A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...

Exiger, the market-leading supply chain AI company and largest provider of supply chain technology to the U.S. Federal ...

HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a ...

Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other ...

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

Dollar General recalled instant coffee that may contain glass. Friendly’s ice cream was pulled from shelves over a potentially dangerous labeling mix-up, and several cheese products from Wegmans were ...

The FDA's controversial rejection of a skin cancer therapy from Replimune Group has prompted Krystal Biotech to shut down of ...